Thirteen PHRI researchers will be presenting at the upcoming European Society of Cardiology (ESC) Congress 2026, taking place August 28 to 31 in Munich, Germany. Their presentations will cover a range of topics, including atrial fibrillation, perioperative care, cardiovascular and stroke prevention, heart failure, and artificial intelligence.
Presentations lineup
Senior scientist Sonia Anand
- “Societal determinants of cardiovascular disease: food systems, policy, and prevention”
Scientist Flavia Borges
- “Predictive value of postoperative N-terminal pro-B-type natriuretic peptide in patients suffering myocardial injury after noncardiac surgery”
- “The new 6th generation high-sensitivity troponin T identifies increased risk of perioperative mortality and major cardiovascular events in noncardiac surge”
Senior scientist Jeff Healey
- “Can we stop oral anticoagulation after successful atrial fibrillation ablation? – discussion”
Senior scientist Darryl Leong
- Late-breaking clinical science: “A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients” (RADICAL PC-2)
Senior scientist David Conen
- Practical seminar co-chair of session entitled: “New challenges and solutions in atrial fibrillation”
- “Smarter perioperative cardiovascular risk assessment: biomarkers, atrial fibrillation, and digital tools”
- “Stroke in atrial fibrillation”
Senior scientist John Eikelboom
- Expert Panel: “The floor is yours: bring your questions on direct oral anticoagulants monitoring and reversal – for whom, when, and why?”
- “Navigating complexities in antithrombotic therapy”
- “Evolution of antithrombotic therapy for stroke prevention: is factor XI inhibition the future?”
Research fellow Silvia Maiorano
- “Prognostic role of a preoperative troponin elevation in patients undergoing urgent or emergency noncardiac surgery: a pooled analysis”
Scientist William McIntyre
- “Association of female sex with adverse clinical events in patients with new-onset post-operative atrial fibrillation: insights from the VISION cardiac surgery cohort”
Senior scientist Shamir Mehta
- “Differences in guideline implementation worldwide”
Research fellow Pascal Meyre
- “Epigenetic scores and aging clocks capture mortality risk in heart failure”
Senior scientist Mike Sharma
- “Factor XI inhibition in clinical trials”
- Late-breaking science: “Dual antiplatelet therapy (DAPT) during the first 90 days post-randomisation in OCEANIC-STROKE: participant characteristics and interaction with asundexian.”
Senior scientist Ashkan Shoamanesh
- “Evidence in focus: OCEANIC-STROKE and what it changes”
- “Engineering safer antithrombotic strategies for secondary stroke prevention – Q&A with the experts”
- “ENRICH-AF: Edoxaban in intracranial hemorrhage survivors with atrial fibrillation”
Senior scientist Harriette Van Spall
- “Smarter use of data from regular care”
- “Social, age, and gender determinants of health in stroke: inequity, access, and outcomes”
- Fireside Chat: “artificial intelligence as a clinical co-pilot: opportunity, responsibility, and liability”
- Discussant review – ADHERE-ASCVD
